Cytotoxic CD8+ T cells (CTLs) are the most powerful effectors in the anti-cancer immune response, because they can detect intracellular antigens presented by major histocompatibility complex (MHC), which constitute the backbone of cancer immunotherapy (43). Here, CD8A is linked to cancer.